Accepting risk in the acceleration of drug development for rare cancers D. Ashley, D. Thomas, L. Gore, R. Carter, J. Zalcberg, R. Otmar, J. Savulescu 2015 / Vol. 16, pp. e190 - e194 / The Lancet Oncology